EXPERT PROFILES:

Professor David Carbone
David Carbone is Professor of Internal Medicine, Director of the James Thoracic Oncology Center at the OSUMC and holds the Barbara J. Bonner Chair in Lung Research. He graduated summa cum laude from Amherst College in 1977 and received an MD and PhD in Molecular Biology and Genetics at Johns Hopkins University in 1985. He then did an Internal Medicine internship and residency at Johns Hopkins Hospital through 1988 followed by a Medical Oncology fellowship

at the National Cancer Institute in Bethesda, MD. At Vanderbilt he was Professor of Medicine, Cell Biology, and Cancer Biology, and Director of the Thoracic/Head and Neck Cancer Program, Director and Principal Investigator of the Vanderbilt Specialized Program of Research Excellence (SPORE) in Lung Cancer for 11 years and PI of the Strategic Partnering to Evaluate Cancer Signatures (SPECS) in Lung Cancer UO1 consortium. He was recruited to The Ohio State University in 2012 to direct the James Thoracic Oncology Center.

His research interests, grant support and publications have been focused on lung cancer, and specifically lung cancer genetics, cancer immunotherapy, tumor-associated immunosuppression mechanisms. He has over 300+ peer-reviewed publications, books and review articles, has served on several NCI grant review panels, including the clinical program project parent committee,

and has continuous NCI funding since early in his career. He has served on the Board of Scientific Counselors for the NCI and as Chair of the Lung Biology subcommittee for the Eastern Cooperative Oncology Group. His a Past President of the International Association for the Study of Lung Cancer (IASLC) and currently co-chair of the NCI/CTEP Thoracic Malignancy Steering Committee.

Dr Manel Haj Mansour
Manel Haj is a Consultant Medical Oncologist and Section Head of Medical Oncology at Aga Khan University Hospital, Nairobi. She is also the current Fellowship Program Director in The Department of Hematology Oncology.

She graduated from the University Tunis, and undertook her Core Internal Medicine and Medical Oncology training the most prestigious University Hospitals in Tunisia where she received her certificate of completion in 2017. She has also received part of training at the Gustave Roussy Institute of cancer treatment in Paris, France.

She has previously worked as consultant medical oncologist and lecturer at Abdurrahman Mami University Hospital, Tunisia and at a leading health care facility in Nairobi.
Dr Haj is passionate about increasing cancer awareness and promoting screening and early detection. She has also a special interest in precision oncology and clinical research and is currently investigator in several clinical trials in the Cancer Research Unit at Aga Khan University Hospital.

She is a member of American (ASCO), European (ESMO) ,Tunisian and Kenyan societies of medical oncology ((STOM  and KESHO).

Dr Allan Njau
Allan Njau is an Assistant Professor in the department of Pathology and Laboratory Medicine at the Aga Khan University Hospital. He holds a bachelor’s degree in medicine and surgery from the University of Nairobi (2008), Master of medicine in Anatomic Pathology from the Aga Khan University (2016) and a fellowship in Molecular Pathology from Augusta University, GA, USA (2020). His interests are in the fields of precision medicine, molecular assays especially for oncology and has a vibrant research agenda in the areas of lung cancer, pathology informatics, endometrial carcinoma, extrapulmonary tuberculosis, Covid-19, gastric cancer and Helicobacter pylori infections.

Dr Njau is dynamic at adopting and developing molecular testing programs and is a proponent of building local capacity for precision medicine oncology. He is a member of the Association for Molecular Pathology and American Association of Cancer Research.

Webinar Recording